2017 Speaker Line Up
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Eszter Sutowski-Nagy at [email protected]
Confirmed Speakers 2017 Include:
Joël Richard, Senior Vice President, Peptides, Head of CMC Development Dreux Site
Ipsen
Lotte Bjerre Knudsen, Scientific Vice President and Senior Principal Scientist
Novo Nordisk A/S
Lutz Jermutus, Senior Director, Product Development Team Leader, Cardiovascular & Metabolic Diseases iMED
MedImmune
Edwin Romijn, Associate Director NMR/MS
Janssen
Eric Valeur, Associate Director New Modalities
AstraZeneca
Michael Wagner, Head of Insulins & Peptides
Sanofi-Aventis Deutschland GmbH
Graham Simpson, Head of Therapeutic Peptide CPU
GlaxoSmithKline
Anouk Dirksen, Senior Principal Scientist, Group Leader and Technology Lead
Pfizer
Christoph Dumelin, Invesitgator, Center for Proteomic Chemistry
Novartis
Ana dos Santos, Principal Scientist
MedImmune
Jarek Juraszek, Principal Scientist
Janssen
Gilles Goetz, Principal Scientist, Analytical Chemistry
Pfizer
Suzanne M. D’Addio, Associate Principal Scientist, Formulation Science
Merck Sharp & Dohme
Stephanie Gueret, Senior Research Scientist
AstraZeneca
Jameson Bothe, Senior Scientist
Merck Sharp & Dohme
Adam Mezo, Senior Research Advisor and Group Leader, Peptide Chemistry
Eli Lilly and Company
Patrick Jimonet, External Innovation & Sourcing, S&BD
Sanofi R&D
Johanna Mora, Senior Research Investigator
Bristol-Myers Squibb
Mark Currie, Senior Vice President, Chief Scientific Officer and President of R&D
Ironwood Pharmaceuticals
Liuhong Chen, Team Leader, Discovery Biology
Bicycle Therapeutics
Ashok Bhandari, Vice President, Chemistry
Protagonist Therapeutics
Mette Svendgaard, Director, Pharmaceutical Development
Zealand Pharma
Steffen Weinbrenner, Head of Drug Discovery
Polyphor
Rie Schultz Hansen, Principal Scientist
Zealand Pharma
Annemieke Madder, Professor
University of Ghent
Sandrine Ongeri, Professor
University of Paris-Sud
Ülo Langel, Professor
Stockholm University
Timo Müller, Associate Director & Head of Division of Molecular Pharmacology
Helmholtz Zentrum München
Follow us on